• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性髓性白血病患者的工作能力:一项丹麦全国队列研究。

Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort Study.

作者信息

Maksten Eva Futtrup, Jensen Jonas Faartoft, Thomsen Gitte, Zenas Ditte Rechter, Jørgensen Maren Poulsgaard, Udby Lene, Fonager Kirsten, Severinsen Marianne Tang

机构信息

Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, 9000 Aalborg, Denmark.

Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark.

出版信息

Cancers (Basel). 2025 May 7;17(9):1585. doi: 10.3390/cancers17091585.

DOI:10.3390/cancers17091585
PMID:40361509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072068/
Abstract

: Patients with chronic myeloid leukemia (CML) have a long life expectancy due to modern treatment. However, treatment may have adverse effects that hamper work ability. : Patients aged 25-60 years diagnosed in 2002-2020 were included in this nationwide matched cohort study examining work ability from diagnosis (index date), including the need for permanent disability compensation (flexible job or disability pension). Each patient was matched 1:5 on sex, birth year, and level of comorbidity with citizens from the general Danish population without CML. The risks of requiring flexible job and disability pension were calculated by cause-specific hazard ratios (HRs) using Cox proportional hazards regression, and the Aalen-Johansen estimator was used to determine cumulative risks. : A total of 489 patients with CML and 2445 matched comparators were included. The median age was 46 years, and males comprised 59.5% of the cohort. Matched comparators were more likely to work at index date and 1, 3, 5, and 10 years after the index date ( < 0.001). The HRs of requiring both flexible job (HR 8.7 (95% confidence interval (CI): 6.1;12.2, < 0.001)) and disability pension (HR 3.7 (95% CI: 2.8;4.9, < 0.001)) were higher among patients diagnosed with CML compared to matched comparators. The cumulative risk of requiring flexible job and disability pension also increased in patients with CML compared to matched comparators ( < 0.001). : Patients with CML have a reduced work ability compared to the general population. More research is needed to determine the cause of their loss of ability to work.

摘要

由于现代治疗方法,慢性粒细胞白血病(CML)患者的预期寿命较长。然而,治疗可能会产生不利影响,从而妨碍工作能力。在这项全国性匹配队列研究中,纳入了2002年至2020年期间诊断出的25至60岁的患者,该研究从诊断(索引日期)开始检查工作能力,包括对永久残疾补偿(灵活工作或残疾抚恤金)的需求。每位患者在性别、出生年份和合并症水平方面与丹麦普通人群中无CML的公民按1:5进行匹配。使用Cox比例风险回归,通过特定病因风险比(HRs)计算需要灵活工作和残疾抚恤金的风险,并使用Aalen-Johansen估计量来确定累积风险。总共纳入了489例CML患者和2445例匹配的对照者。中位年龄为46岁,男性占队列的59.5%。匹配的对照者在索引日期以及索引日期后1、3、5和10年更有可能工作(P<0.001)。与匹配的对照者相比,诊断为CML的患者需要灵活工作(HR 8.7(95%置信区间(CI):;12.2,P<0.001))和残疾抚恤金(HR 3.7(95%CI:2.8;4.9,P<0.001))的HRs更高。与匹配的对照者相比,CML患者需要灵活工作和残疾抚恤金的累积风险也增加了(P<0.001)。与普通人群相比,CML患者的工作能力降低。需要更多的研究来确定他们工作能力丧失的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc05/12072068/f0442aeb9703/cancers-17-01585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc05/12072068/39d793ea3edc/cancers-17-01585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc05/12072068/f0442aeb9703/cancers-17-01585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc05/12072068/39d793ea3edc/cancers-17-01585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc05/12072068/f0442aeb9703/cancers-17-01585-g002.jpg

相似文献

1
Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort Study.慢性髓性白血病患者的工作能力:一项丹麦全国队列研究。
Cancers (Basel). 2025 May 7;17(9):1585. doi: 10.3390/cancers17091585.
2
Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study.急性淋巴细胞白血病治疗后的工作残疾与重返工作岗位:一项丹麦全国队列研究
Clin Epidemiol. 2024 Mar 14;16:191-202. doi: 10.2147/CLEP.S444270. eCollection 2024.
3
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study.淋巴瘤后的工作残疾与重返工作岗位:一项丹麦全国队列研究。
Clin Epidemiol. 2023 Mar 14;15:337-348. doi: 10.2147/CLEP.S399488. eCollection 2023.
4
Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study.丹麦人群队列研究:事件性静脉血栓栓塞后永久性与工作相关残疾抚恤金的风险。
PLoS Med. 2021 Aug 31;18(8):e1003770. doi: 10.1371/journal.pmed.1003770. eCollection 2021 Aug.
5
Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study.老年淋巴瘤患者痴呆风险:一项丹麦全国匹配队列研究。
J Geriatr Oncol. 2024 Jan;15(1):101672. doi: 10.1016/j.jgo.2023.101672. Epub 2023 Nov 16.
6
Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse.子宫颈癌幸存者与普通人群相比的工作日损失:治疗和复发的影响。
J Cancer Surviv. 2016 Jun;10(3):514-23. doi: 10.1007/s11764-015-0496-1. Epub 2015 Nov 12.
7
Work ability in rheumatoid arthritis patients: a register study on the prospective risk of exclusion and probability of returning to work.类风湿关节炎患者的工作能力:一项关于预期排除风险和重返工作岗位可能性的前瞻性研究。
Rheumatology (Oxford). 2017 Jul 1;56(7):1135-1143. doi: 10.1093/rheumatology/kex064.
8
Sick Leave and Disability Pension in Prevalent Patients With Crohn's Disease.流行的克罗恩病患者的病假和残疾抚恤金。
J Crohns Colitis. 2018 Nov 28;12(12):1418-1428. doi: 10.1093/ecco-jcc/jjy123.
9
Increased risk of long-term sickness absence, lower rate of return to work, and higher risk of unemployment and disability pensioning for thyroid patients: a Danish register-based cohort study.甲状腺患者长期病假风险增加、复工率降低、失业和领取残疾抚恤金风险更高:一项基于丹麦登记处的队列研究。
J Clin Endocrinol Metab. 2014 Sep;99(9):3184-92. doi: 10.1210/jc.2013-4468. Epub 2014 Jun 17.
10
Association between maternal employment status and presence of children with major congenital anomalies in Denmark.丹麦母亲就业状况与儿童主要先天畸形存在的关联。
BMC Public Health. 2024 Mar 6;24(1):715. doi: 10.1186/s12889-024-18190-w.

本文引用的文献

1
Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study.急性淋巴细胞白血病治疗后的工作残疾与重返工作岗位:一项丹麦全国队列研究
Clin Epidemiol. 2024 Mar 14;16:191-202. doi: 10.2147/CLEP.S444270. eCollection 2024.
2
Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.决定慢性髓性白血病患者对酪氨酸激酶抑制剂依从性的危险因素。
J Oncol Pharm Pract. 2024 Jul;30(5):902-906. doi: 10.1177/10781552231196130. Epub 2023 Sep 25.
3
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.
骨髓增殖性肿瘤患者的劳动力市场从属关系:一项基于人群的匹配队列研究。
Acta Oncol. 2023 Oct;62(10):1286-1294. doi: 10.1080/0284186X.2023.2251670. Epub 2023 Sep 1.
4
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study.淋巴瘤后的工作残疾与重返工作岗位:一项丹麦全国队列研究。
Clin Epidemiol. 2023 Mar 14;15:337-348. doi: 10.2147/CLEP.S399488. eCollection 2023.
5
Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study.酪氨酸激酶抑制剂治疗慢性髓性白血病对病假工资补偿的影响:一项全国性队列研究。
Support Care Cancer. 2022 Jun;30(6):5431-5440. doi: 10.1007/s00520-022-06968-w. Epub 2022 Mar 18.
6
Mental health among patients with non-Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators.非霍奇金淋巴瘤患者的心理健康:一项丹麦全国性研究,调查 8750 名患者和 43750 名匹配对照者的精神药物使用情况。
Am J Hematol. 2022 Jun 1;97(6):749-761. doi: 10.1002/ajh.26538. Epub 2022 Mar 29.
7
Chronic Myeloid Leukemia in 2020.2020年的慢性髓系白血病。
Hemasphere. 2020 Sep 30;4(5):e468. doi: 10.1097/HS9.0000000000000468. eCollection 2020 Oct.
8
Risk of being granted disability pension among incident cancer patients before and after a structural pension reform: A Danish population-based, matched cohort study.丹麦基于人群的、配对队列研究:结构性养老金改革前后新发癌症患者获得残疾养老金的风险。
Scand J Work Environ Health. 2020 Jul 1;46(4):382-391. doi: 10.5271/sjweh.3883. Epub 2020 Jan 13.
9
The impact of chronic myeloid leukemia on employment: the French prospective study.慢性髓性白血病对就业的影响:法国前瞻性研究。
Ann Hematol. 2019 Mar;98(3):615-623. doi: 10.1007/s00277-018-3549-5. Epub 2018 Nov 17.
10
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.伊马替尼作为慢性粒细胞白血病一线治疗的评估:随机CML研究IV的10年生存结果及非CML决定因素的影响
Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14.